KATE vs PaceMate
Three PubMed papers carry Mednition-employed authors, among them a 2025 descriptive study of pre-eclampsia identification at triage. KATE Sepsis has held an FDA Breakthrough Device Designation since November 2023, and openFDA holds no 510(k) record for either vendor.
PaceMate sells to device clinics, a separate purchase from an ED's. It states ISO/IEC 27001:2022, HITRUST r2, SOC 2 Type 2, SOC 3 and HIPAA with a BAA available, hosted on AWS, and lists Epic, Oracle Health and athenahealth as bi-directional. Auto-Triage ranks device alerts by clinical priority, and the vendor claims a 61% drop in physician alert burden and 73% fewer loop recorder false-positive alerts. PubMed shows ten PaceMate-affiliated papers, none with the product in the title. The vendor says 39 peer-reviewed studies.
Decision support · Reviewed November 2, 2026
When to pick each one
KATE
- Aimed at emergency department triage and sepsis
- Adventist Health White Memorial named as customer
PaceMate
- Auto-Triage ranks device alerts by clinical priority
- Bi-directional Epic, Oracle Health and athenahealth
- ISO 27001, HITRUST r2 and SOC 2 Type 2
Score
Each row shows points earned of points available under the published rubric.
KATE
12of 100
PaceMate
47of 100
| Dimension | KATE | PaceMate | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 10 / 10 | -10 |
| EHR integrations (count) | 0 / 5.6 | 1.7 / 5.6 | -1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 4.8 / 4.8 | -4.8 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 14.7 / 21 | -14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 4.5 / 9 | -4.5 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 6 / 6 | 0 / 6 | +6 |
Scroll horizontally to see every column.
Pricing
KATE
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
PaceMate
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
KATE
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
PaceMate
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
3 PubMed records name PaceMate.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | KATE | PaceMate |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, Oracle Health, athenahealth |
| Founded | 2014 | n/a |
| HQ | US | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.


